Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Liraglutide
Victoza
Not routinely available
SMC (1044/15)
02/02/2022
Indication
For the treatment of adults with type 2 diabetes mellitus to achieve glycaemic control in combination with basal insulin when this, together with diet and exercise, does not provide adequate glycaemic control.
Therapeutic Area
Endocrine system
Status Description
Not routinely available as local clinical experts do not wish to add the medicine to the formulary at this time or there is a local preference for alternative medicines
Formulation
6mg/mL prefilled pen for injection (3mL)